A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro

7K views

⸱

DOI:

10.3791/56785

⸱

January 9th, 2018

 ,  ,  ,  ,  ,  ,  ,  ,  , 

In This Article

Summary

Here, we present a protocol to mass-produce gene-silencing murine NK cells by using a feeder-free differentiation system for mechanistic study in vitro and in vivo.

Abstract

Natural killer (NK) cells belong to the innate immune system and are a first-line anti-cancer immune defense; however, they are suppressed in the tumor microenvironment and the underlying mechanism is still largely unknown. The lack of a consistent and reliable source of NK cells limits the research progress of NK cell immunity. Here, we report an in vitro system that can provide high quality and quantity of bone marrow-derived murine NK cells under a feeder-free condition. More importantly, we also demonstrate that siRNA-mediated gene silencing successfully inhibits the E4bp4-dependent NK cell maturation by using this system. Thus, this novel in vitro NK cell differentiating system is a biomaterial solution for immunity research.

Introduction

Cancer progression is largely dependent on the tumor microenvironment1,2, including host-derived immunocytes, e.g., NK cells. Several studies demonstrated that intratumoral NK cells are negatively correlated with the tumor progression3,4. In addition, clinical studies showed that NK cell adoptive therapy is a possible strategy for cancer5,6,7,8,9. NK cell-based cancer immunotherapy ....

Access restricted. Please log in or start a trial to view this content.

Protocol

The protocol for obtaining and differentiating bone marrow-derived NK cells (BM-NK) is based on previously published methods20,21,22. All procedures with mice have been approved by the Animal Ethics Experimental Committee (AEEC) at the Chinese University of Hong Kong.

1. Preparation of OP9 Conditional Medium

  1. Culture the murine stroma cell line OP9 in alpha-MEM containing 20% FBS, 100 U/mL penicillin G and 100 µg/mL streptomycin, at 37 °C in a humidified atmosphere of air/CO2 (95%:5%).
    1. Count the cells wit....

Access restricted. Please log in or start a trial to view this content.

Results

Representative results are obtained following the described protocol. Total bone marrow suspension cells were cultivated under the feeder-free differentiation system for 11 days; significant increase in proliferation rate was observed by day 7 compared with the number of total cells on day 0 (Figure 1A). Mature NK cells with high nuclear to cytoplasmic ratio and granule-rich cytoplasm morphology were found by day 6 in the system (

Access restricted. Please log in or start a trial to view this content.

Discussion

In the present work, we have described a novel method for producing bone marrow-derived murine NK cells in vitro. The cell feeder in the original system21,22 is successfully replaced by the conditional medium of OP9 cells, which largely increased the stability of the differentiation system. In addition, the system can produce high quantity and purity of mature NK cells for in vitro as well as in vivo assays, which can facilitate the mec.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

This study was supported by the Research Grants Council of Hong Kong (GRF 468513, CUHK3/CRF/12R) and the Innovation and Technology Fund of Hong Kong (ITS/227/15, ITS InP/164/16, ITS-InP/242/16), Direct Grant for Research-CUHK (2016.035), and Hong Kong Scholar Program.

H.-Y.L. designed and supervised all experiments and contributed to manuscript preparation. P.M.-K.T. performed experiments, analyzed data and contributed to manuscript preparation. P.C.-T. T., J.Y.-F.C., J.S.-C.,H., Q.-M.W., and G.-Y.L. collected animal samples and participated in animal experiments. J.S., X.-R.H., and K.-F.T. contributed to manuscript preparation.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
OP9 cell lineATCCATCC® CRL-2749™
MEM α, no nucleosidesGibco22561021
Fetal Bovine SerumGibco10500064
PBS, pH 7.4Gibco10010049
Recombinant Murine IL-7PEPROTECH217-17
Recombinant Murine SCFPEPROTECH250-03
Recombinant Murine Flt3-LigandPEPROTECH250-31L
Recombinant Murine IL-2PEPROTECH212-12
Lipofectamin RNAiMAX Transfection ReagentInvitrogen1377815
IC Fixation Buffer eBioscience00-8222-49
Flow Cytometry Staining Buffer eBioscience00-4222-26
PE-conjugated anti-mouse CD244eBioscience12-2441-83
Cy3-conjugated anti-mouse NKp46Biossbs-2417R-cy3
Nonsense control (NC)RibobiosiN05815122147
siRNA against mouse E4BP4 mRNARibobioN/A5′-GAUGAGGGUGUA
GUGGGCAAGUCUU-3′

References

  1. Schreiber, R. D., Old, L. J., Smyth, M. J. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science. 331 (6024), 1565-1570 (2011).
  2. Junttila, M. R., de Sauvage, F. J. Influence of tumour micro-environment heterogeneity on the....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Murine NK CellsBone Marrow DerivedOP9 Conditioned MediumsiRNA Gene SilencingE4bp4 InhibitionFlow Cytometry AnalysisTGF Beta-1 Smad3Cell Culture Protocol